Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Hepatitis C Virus (HCV)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02781571
What this trial is testing

Sofosbuvir/Velpatasvir Fixed Dose Combination in Participants With Chronic Hepatitis C Virus Infection Who Have Received a Liver Transplant

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 79
Not applicableStudy completedNCT01771653
What this trial is testing

Comparison of Two Triple Regimens for Treatment and Retreatment of Chronic Hepatitis C Infection

Who this might be right for
Hepatitis C Infection
Southern Illinois University 37
Large-scale testing (Phase 3)Study completedNCT02753699
What this trial is testing

Long Term Follow-up Study to Assess Durability of Sustained Virologic Response in Alisporivir-treated Hepatitis C Patients

Who this might be right for
Hepatitis C
Debiopharm International SA 723
Large-scale testing (Phase 3)Study completedNCT01833533
What this trial is testing

Evaluate Chronic Hepatitis C Infection in Adults With Genotype 1a Infection

Who this might be right for
Chronic Hepatitis C Infection
AbbVie 305
Post-approval studies (Phase 4)Study completedNCT02624063
What this trial is testing

Randomized Clinical Trial of Sofosbuvir in Combination With Daclatasvir or Simeprevir for 12 Weeks in Non-cirrhotic Subjects Infected With Chronic Hepatitis C Virus Genotype 1 (TNT)

Who this might be right for
Hepatitis C, Chronic
Federal University of São Paulo 121
Large-scale testing (Phase 3)Study completedNCT02723084
What this trial is testing

Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Japanese Adults With Genotype 2 Chronic Hepatitis C Virus Infection

Who this might be right for
Chronic Hepatitis C VirusHepatitis C Virus
AbbVie 136
Not applicableEnded earlyNCT01340573
What this trial is testing

Evaluating Safety and Efficacy In Hepatitis C Patients After PegIntron Pen Treatment (Study P04896)

Who this might be right for
Chronic Hepatitis C
Merck Sharp & Dohme LLC 3
Large-scale testing (Phase 3)Study completedNCT03219216
What this trial is testing

Evaluate the Efficacy and Safety of Glecaprevir (GLE)/Pibrentasvir (PIB) in Treatment-Naive Adults in Brazil With Chronic Hepatitis C Virus (HCV) Genotype 1 - 6 Infection

Who this might be right for
Hepatitis C Virus (HCV)
AbbVie 100
Not applicableStudy completedNCT02027493
What this trial is testing

Hansenula-Derived Pegylated-Interferon Alpha-2a in Egyptian Children With Chronic HCV

Who this might be right for
Hepatitis C, Chronic
National Liver Institute, Egypt 46
Not applicableStudy completedNCT01447446
What this trial is testing

An Observational Study on Dual And Triple Therapies Based on Peginterferon Alfa (e.g. Pegasys) in Patients With Chronic Hepatitis C

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 4,442
Testing effectiveness (Phase 2)Study completedNCT03020095
What this trial is testing

Efficacy and Safety of Ravidasvir + Danoprevir/r 12-week Oral Therapy in Treatment-Naive Non Cirrhotic G1 CHC Taiwan

Who this might be right for
Chronic Hepatitis C
Ascletis Pharmaceuticals Co., Ltd. 38
Not applicableStudy completedNCT00705666
What this trial is testing

Treatment of Patients With Chronic Hepatitis C With PegIntron as Monotherapy or in Combination With Ribavirin (Study P04437)(COMPLETED)

Who this might be right for
Hepatitis C, ChronicHepacivirus
Merck Sharp & Dohme LLC 789
Not applicableEnrolling By InvitationNCT07298577
What this trial is testing

Use of Gender, Age, Alfa-fetoprotein (AFP), and Des-gamma-carboxyprothrombin (PIVKA-II) or GAAD Score in Addition to Ultrasound for Surveillance of People At-risk for Developing Hepatocellular Carcinoma in Asia in Order to Detect Early Liver Cancer

Who this might be right for
Liver CirrhosisHepatitis B, ChronicHepatitis C, Chronic+1 more
Siriraj Hospital 2,100
Large-scale testing (Phase 3)Study completedNCT03995485
What this trial is testing

KW-136 With Sofosbuvir for Chinese Adults With Chronic Hepatitis C

Who this might be right for
Hepatitis C, Chronic
Kawin Technology Share-holding Co., Ltd. 371
Post-approval studies (Phase 4)Ended earlyNCT00209898
What this trial is testing

Hepatitis C Treatment of Inmates

Who this might be right for
Chronic Hepatitis C
Haukeland University Hospital 42
Not applicableUnknownNCT05401136
What this trial is testing

Evaluating the Chain of Addiction Care (CAC)

Who this might be right for
Hepatitis C, ChronicSubstance Use Disorders
Radboud University Medical Center 1,000
Testing effectiveness (Phase 2)Study completedNCT01974687
What this trial is testing

Single and Multiple Dose Study of Uprifosbuvir (MK-3682/IDX21437) in Healthy and Hepatitis C Virus (HCV)-Infected Participants (MK-3682-001)

Who this might be right for
Chronic Hepatitis C
Merck Sharp & Dohme LLC 178
Early research (Phase 1)Study completedNCT02063607
What this trial is testing

The Study of Safety, Pharmacokinetics, Pharmacodynamics of Peglamda (Peginterferon Lamda 1) on Healthy Volunteers and the Preliminary Evaluation of Peglamda and Hepasig (Ribavirin) Treatment's Effects on Chronic Hepatitis C Patients

Who this might be right for
Hepatitis C
Nanogen Pharmaceutical Biotechnology Joint Stock Company 60
Large-scale testing (Phase 3)Study completedNCT02442271
What this trial is testing

Evaluate the Efficacy and Safety of Three Experimental Drugs in Adults With Hepatitis C Virus Infection, Who Are Either Treatment-naive or Treatment-experienced in Brazil

Who this might be right for
Chronic Hepatitis C Infection
AbbVie 222
Not applicableStudy completedNCT02505243
What this trial is testing

Evaluation of RIBAvirin Plasma COncentrations in Patients With Chronic Hepatitis C Infection Routinely Treated With Modern DAA Regimens

Who this might be right for
HCV CoinfectionHepatitis C
Radboud University Medical Center 252
Next Page